Press releases

In this section you can view all the latest news from across the Charity, from fundraising challenges to our information services and large-scale campaigns. Our team respond rapidly to new research, as well as to issues affecting men with prostate cancer and their families as they happen. Read our latest statements and responses on all aspects of the disease, including funding, treatment accessibility and emerging research.You can also search our archive of press releases.  

To register to receive our latest press releases please contact the press office, at pressoffice@prostatecanceruk.org.

Our busy Media and PR Team provide journalists with the most up-to-date and precise information on all aspects of prostate cancer, as quickly as possible. We deliver expert responses to the latest developments in prostate cancer research, as well as facts, figures and spokespeople to guide you through the issues surrounding the disease.

We also have access to around 150 people across the UK who have been affected by prostate cancer, and are willing to share their experiences with the media - our Media Talkers scheme.

In the Media Centre, you will find all our latest news releases and comments, as well as the resources you need to shape an article, including facts, statistics and profiles of our spokespeople.  If you do need any further information, you can also find the contact details for the Media and PR Team who will be able to help. 

Please note that the Media Centre is a tool for journalists. For all other enquiries, please contact the Prostate Cancer UK switchboard on 020 8222 7622.

Press releases

Prostate Cancer UK welcomes SMC abiraterone approval

Prostate Cancer UK (formerly The Prostate Cancer Charity) has welcomed the Scottish Medicines Consortium’s (SMC) decision to recommend abiraterone for use on the NHS in Scotland for men with incurable prostate cancer.

Scientists pinpoint gene instrumental to prostate formation and cancer growth

Researchers funded by Prostate Cancer UK and the Medical Research Council (MRC) have taken a crucial step forward by identifying a gene that’s potentially instrumental to the growth of both the prostate gland and prostate tumours. Scientists believe this discovery – published today in ‘PLOS ONE’ - could lead to improvements in prostate cancer diagnosis and treatment in the future.